MSK Virtual 9th Annual State-of-the-Art in Thrombosis and Hemostasis Symposium

MSK 9th Annual Virtual State-of-the-Art in Thrombosis and Hemostasis Symposium is organized by Memorial Sloan Kettering Cancer Center (MSKCC). This Online CME Course will be held as a fully web-based course on Oct 18, 2020. 

How many CME credits can be earned by attending MSK CME Course?
Accreditation:
AMA Credit Designation Statement:
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

What is the significance of the MSK CME Course?
Course Overview:
This course is designed to provide an important annual educational forum for Hematology and Oncology doctors. The ultimate objective of this activity is to enhance physician understanding of the disease state and treatment advances for the benefit of patients. 

What are the topics addressed in the MSK CME Course?
2020 Symposium Topics:
• New Innovations in Bleeding Disorders
• New Innovations on Thrombotic Disorders
• The COVID19-Related Coagulopathy - Pathophysiology and Management
• Coagulation Changes with MPN and Hematologic Malignancies• Platelet Focus Symposium
• Thrombotic Microangiopathy
• Platelet Focus Symposium

Please note that the 2020 program topics are subject to change. A complete agenda and faculty list will be made available online soon.

What are the objectives of the MSK CME Course?
Course Objectives:
• Evaluate the novel scientific updates in the diagnosis and management of hemorrhagic disorders.
• Examine the current scientific updates in the diagnosis and management of thrombotic disorders.
• Analyze the recent scientific updates in the area of platelet disorders, along with the Immune Thrombocytopenic Purpura, Chemotherapy-Induced Thrombocytopenia, Thrombotic Microangiopathy, and anti-platelet therapy.